Gestational Diabetes is a 2-part program. Your personal diabetes coach will guide you through a 4-month structured program that gives you the information and tools you need to successfully manage gestational diabetes. Then you'll receive 2 additional months of access to your coach so you can continue to ask questions and receive support after childbirth.
Thousands of people with type-2 diabetes in the UK are missing out on obesity surgery that would slash blood sugars and even lead to remission in some cases, a team of experts say. Leading surgeon Prof Francesco Rubino described the gut operation as "the closest thing to a cure" available. UK guidelines already recommend the surgery for some patients. But experts argue the guidance needs to be expanded and made more prominent, as most doctors do not offer it. About three million people in the UK have type-2 diabetes, which can lead to serious complications, including kidney failure, blindness and heart disease.
Diabetes has traditionally been classified as either type 1 or type 2. Ahlqvist et al. analyzed nearly 15,000 Scandinavian patients to refine the conventional diabetes classification system. Using six biological parameters and phenotype-based clustering, the researchers found that patients were stratified into five subgroups. These subgroups differed in genetic associations, disease progression, and medical outcomes. For example, individuals in the insulin-deficient subgroup were more susceptible to developing retinopathy. In contrast, the patients who were most resistant to insulin were more prone to developing diabetic kidney disease than other subgroups.
People in England at risk of type-2 diabetes are to be offered healthy-lifestyle support by the NHS to help them prevent the condition developing. The new national programme will be launched this spring, with the aim of helping 20,000 people this year. Patients will be offered 13 sessions focusing on exercise, education and lifestyle changes. GPs are being asked to identify the people who would benefit the most from the programme. This will be done through blood-glucose testing and monitoring for signs of pre-diabetes.
Verily, Google's former Life Sciences division, teamed up with a French pharmaceutical company to help treat diabetes just a few months ago. Now, it has joined forces with Nikon to enhance the screening process for diabetic retinopathy and macular edema -- diabetes-related eye diseases and two of the leading causes of blindness in adults. They want to create machine learning-enabled retinal imaging technologies that can detect the diseases in their early stages. That way, doctors can step in and prevent the patients from going blind whenever possible. The details of the partnership aren't entirely clear at this point, but Nikon will apparently use its expertise in "optical engineering and precision manufacturing, its proprietary ultra-widefield technology and strong commercial presence among eyecare specialists."